Merck Unit Sues TriGen Over Folic Acid Patents
A Swiss affiliate of Merck KgaA and Pamlab LLC have accused TriGen Laboratories Inc. of falsely marketing two of its dietary supplement product lines as generic equivalents and infringing six patents...To view the full article, register now.
Already a subscriber? Click here to view full article